Skip to content

Clinical study for Zhao's Thunder-fire moxibustion in the treatment of cervical spondylotic radiculopathy

Clinical study for Zhao's Thunder-fire moxibustion in the treatment of cervical spondylotic radiculopathy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018820
Enrollment
Unknown
Registered
2018-10-11
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical spondylotic radiculopathy

Interventions

Group 1:Zhao's Thunder-fire Moxibustion, Acupoints: Tianzhu, Bailao, Dazhu
Group 2:Oral ibuprofen sustained release capsule

Sponsors

The First Affiliated Hospital,Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) man or women aged 18 to 65 year, (2) the main symptoms and signs are syndromes of pain and numbness distributing along spinal nerve roots, (3) have positive intervertebral foramen extrusion and/or brachial plexus pull tests , (4) the clinical manifestations and imaging are consistent with the clinical syndromes,(5) those who can understand scales

Exclusion criteria

Exclusion criteria: (1)disorders such as thoracic outlet syndrome, tennis elbow, carpal tunnel syndrome, cubital tunnel syndrome, periarthritis of the shoulder, tendonitis of biceps brachii, or a diagnosis of acute spinal cord injury, (2)acute spinal cord inflammation, symptoms of cervical vertigo and abnormal changes on Transcranial Doppler (TCD), (3)acupuncture treatment or medication for the disease during the past 1 month, (4)acute or chronic infection, trauma, fever or allergy during the previous 2 weeks, (5) any other conditions including active skin infection, clotting disorders, administration of an anticoagulant agent,(6) severe primary disease or infectious diseases including liver, heart or kidney disease, hematopoietic system, endocrine system disease, or pregnancy or breastfeeding,(7) severe psychiatric or psychological disorder related to severe neurosis, dementia and unable to communicate or provide self-care, (8) patients who are afraid of moxibustion.

Design outcomes

Primary

MeasureTime frame
Yasuhisa Tanaka 20 Score Scale;

Secondary

MeasureTime frame
Quality of Life Assessment (SF-36);Neck Disability Index score scale (NDI);Short Form McGill Pain Questionnaire-2 (SF-MPQ-2);

Countries

China

Contacts

Public ContactXinghua Chen

The First Affiliated Hospital,Guangzhou University of Traditional Chinese Medicine

xinghuac@outlook.com+86 13631382393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026